Bank of America’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16M Buy
1,037,163
+718,805
+226% +$11.1M ﹤0.01% 2405
2025
Q1
$4.73M Sell
318,358
-44,159
-12% -$657K ﹤0.01% 3251
2024
Q4
$4.8M Sell
362,517
-533,765
-60% -$7.07M ﹤0.01% 3067
2024
Q3
$12.7M Buy
896,282
+29,223
+3% +$416K ﹤0.01% 2444
2024
Q2
$11.2M Sell
867,059
-616,950
-42% -$7.98M ﹤0.01% 2466
2024
Q1
$20.6M Buy
1,484,009
+649,696
+78% +$9.02M ﹤0.01% 1959
2023
Q4
$11.9M Sell
834,313
-1,365,965
-62% -$19.5M ﹤0.01% 2252
2023
Q3
$34M Buy
2,200,278
+1,354,853
+160% +$21M ﹤0.01% 1347
2023
Q2
$13.3M Sell
845,425
-451,412
-35% -$7.09M ﹤0.01% 2073
2023
Q1
$21.4M Buy
1,296,837
+440,000
+51% +$7.25M ﹤0.01% 1786
2022
Q4
$13.4M Sell
856,837
-252,419
-23% -$3.94M ﹤0.01% 2040
2022
Q3
$14.4M Buy
1,109,256
+262,641
+31% +$3.41M ﹤0.01% 1900
2022
Q2
$11.9M Sell
846,615
-2,541,293
-75% -$35.7M ﹤0.01% 2168
2022
Q1
$48.5M Buy
3,387,908
+231,268
+7% +$3.31M ﹤0.01% 1243
2021
Q4
$43M Sell
3,156,640
-910,856
-22% -$12.4M ﹤0.01% 1326
2021
Q3
$66.6M Buy
4,067,496
+1,916,142
+89% +$31.4M 0.01% 1066
2021
Q2
$36.2M Sell
2,151,354
-510,290
-19% -$8.59M ﹤0.01% 1438
2021
Q1
$48.6M Buy
2,661,644
+731,126
+38% +$13.4M 0.01% 1198
2020
Q4
$35.1M Sell
1,930,518
-1,268,439
-40% -$23.1M ﹤0.01% 1258
2020
Q3
$57.1M Buy
3,198,957
+100,994
+3% +$1.8M 0.01% 939
2020
Q2
$55.5M Buy
3,097,963
+33,459
+1% +$600K 0.01% 909
2020
Q1
$46.5M Sell
3,064,504
-894,748
-23% -$13.6M 0.01% 917
2019
Q4
$78.1M Sell
3,959,252
-87,627
-2% -$1.73M 0.01% 817
2019
Q3
$69.6M Buy
4,046,879
+304,513
+8% +$5.24M 0.01% 839
2019
Q2
$66.2M Buy
3,742,366
+1,340,772
+56% +$23.7M 0.01% 860
2019
Q1
$48.9M Sell
2,401,594
-4,496,879
-65% -$91.6M 0.01% 1008
2018
Q4
$116M Buy
+6,898,473
New +$116M 0.02% 551